Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

被引：145

作者：

Agewall, Stefan ^{[1
]}

Cattaneo, M. ^{[2
]}

Collet, J. P. ^{[3
]}

Andreotti, F. ^{[4
]}

Lip, G. Y. H. ^{[5
]}

Verheugt, F. W. A. ^{[6
]}

Huber, K. ^{[7
]}

Grove, E. L. ^{[8
]}

Morais, J. ^{[9
]}

Husted, S. ^{[10
]}

Wassmann, S. ^{[11
]}

Rosano, G. ^{[12
]}

Atar, D. ^{[1
]}

Pathak, A. ^{[13
,14
]}

Kjeldsen, K. ^{[15
,16
]}

Storey, R. F. ^{[17
]}

机构：

[1] Univ Oslo, Oslo Univ Hosp, Dept Cardiol, Oslo, Norway

[2] Univ Milan, Osped San Paolo, Dipartimento Sci Salute, Milan, Italy

[3] Univ Paris 06, INSERM, Grp Hosp Pitie Salpetriere, AP HP,U937,Inst Cardiol, F-75013 Paris, France

[4] Catholic Univ Hosp, Dept Cardiovasc Sci, Rome, Italy

[5] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England

[6] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands

[7] Wilhelminenhospital, Dept Med 3, Vienna, Austria

[8] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark

[9] Ctr Hosp Leiria Pombal, Serv Cardiol, Leiria, Portugal

[10] Arhus Univ Hosp, Dept Cardiol, Aarhus, Denmark

[11] Isar Kliniken, Dept Cardiol, Isar Heart Ctr, Munich, Germany

[12] IRCCS San Raffaele Pisana, Dept Med Sci, I-235 Rome, Italy

[13] CHU, Toulouse, France

[14] Univ Toulouse 3, Fac Med Toulouse, Inst Malad Metabol & Cardiovasc U104, INSERM, F-31062 Toulouse, France

[15] Rigshosp, Ctr Heart, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark

[16] Aalborg Univ, Fac Med, Aalborg, Denmark

[17] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England

来源：

EUROPEAN HEART JOURNAL | 2013年 / 34卷 / 23期

关键词：

ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; DABIGATRAN ETEXILATE; ANTIPLATELET THERAPY; PLATELET INHIBITION; ATRIAL-FIBRILLATION; DRUG-INTERACTIONS; ADVERSE OUTCOMES; TREATED PATIENTS; CONCOMITANT USE;

D O I：

10.1093/eurheartj/eht042

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1708 / +

页数：8

共 52 条

[11] Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].

Goldstein, JA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355

[12] Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor Insights From the Platelet Inhibition and Patient Outcomes Trial [J].

Goodman, Shaun G. ;

Clare, Robert ;

Pieper, Karen S. ;

Nicolau, Jose C. ;

Storey, Robert F. ;

Cantor, Warren J. ;

Mahaffey, Kenneth W. ;

Angiolillo, Dominick J. ;

Husted, Steen ;

Cannon, Christopher P. ;

James, Stefan K. ;

Kilhamn, Jan ;

Steg, P. Gabriel ;

Harrington, Robert A. ;

Wallentin, Lars .

CIRCULATION, 2012, 125 (08) :978-986

[13] Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].

Granger, Christopher B. ;

Alexander, John H. ;

McMurray, John J. V. ;

Lopes, Renato D. ;

Hylek, Elaine M. ;

Hanna, Michael ;

Al-Khalidi, Hussein R. ;

Ansell, Jack ;

Atar, Dan ;

Avezum, Alvaro ;

Cecilia Bahit, M. ;

Diaz, Rafael ;

Easton, J. Donald ;

Ezekowitz, Justin A. ;

Flaker, Greg ;

Garcia, David ;

Geraldes, Margarida ;

Gersh, Bernard J. ;

Golitsyn, Sergey ;

Goto, Shinya ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Horowitz, John ;

Mohan, Puneet ;

Jansky, Petr ;

Lewis, Basil S. ;

Luis Lopez-Sendon, Jose ;

Pais, Prem ;

Parkhomenko, Alexander ;

Verheugt, Freek W. A. ;

Zhu, Jun ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992

[14] Gastrointestinal Events with Clopidogrel: A Nationwide Population-Based Cohort Study [J].

Grove, Erik Lerkevang ;

Wurtz, Morten ;

Schwarz, Peter ;

Jorgensen, Niklas Rye ;

Vestergaard, Peter .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (02) :216-222

[15] Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine [J].

Hagihara, Katsunobu ;

Nishiya, Yumi ;

Kurihara, Atsushi ;

Kazui, Miho ;

Farid, Nagy A. ;

Ikeda, Toshihiko .

DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (06) :412-420

[16] ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J].

Hamm, Christian W. ;

Bassand, Jean-Pierre ;

Agewall, Stefan ;

Bax, Jeroen ;

Boersma, Eric ;

Bueno, Hector ;

Caso, Pio ;

Dudek, Dariusz ;

Gielen, Stephan ;

Huber, Kurt ;

Ohman, Magnus ;

Petrie, Mark C. ;

Sonntag, Frank ;

Uva, Miguel Sousa ;

Storey, Robert F. ;

Wijns, William ;

Zahger, Doron .

EUROPEAN HEART JOURNAL, 2011, 32 (23) :2999-3054

[17] Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome [J].

Ho, P. Michael ;

Maddox, Thomas M. ;

Wang, Li ;

Fihn, Stephan D. ;

Jesse, Robert L. ;

Peterson, Eric D. ;

Rumsfeld, John S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09) :937-944

[18] Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice [J].

Huisman, Menno V. ;

Lip, Gregory Y. H. ;

Diener, Hans-Christoph ;

Brueckmann, Martina ;

van Ryn, Joanne ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) :838-847

[19] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration A Systematic Meta-Analysis [J].

Hulot, Jean-Sebastien ;

Collet, Jean-Philippe ;

Silvain, Johanne ;

Pena, Ana ;

Bellemain-Appaix, Anne ;

Barthelemy, Olivier ;

Cayla, Guillaume ;

Beygui, Farzin ;

Montalescot, Gilles .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (02) :134-143

[20]

Humphries TJ, 1999, ALIMENT PHARM THER, V13, P18

← 1 2 3 4 5 6 →